PDF: Update on Drugs & Devices: September – October 2021

PDF Download: The update covers: Tazarotene lotion, 0.045% – Arazlo™ (Bausch Health), Anifrolumab-fnia IV use – Saphnelo™ (AstraZeneca), Immune globulin intravenous (human) 10% – Octagam® 10% (Octapharma), Odevixibat capsule – Bylvay™ (Albireo Pharma) and other treatments..